National Cancer Institute; Amended Notice of Meeting, 9932 [2013-03116]

Download as PDF tkelley on DSK3SPTVN1PROD with NOTICES 9932 Federal Register / Vol. 78, No. 29 / Tuesday, February 12, 2013 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Healthcare Delivery and Methodologies Date: March 6, 2013 Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call) Contact Person: John Newman, Ph.D., Scientific Review Officer, HDM IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3158, MSC 7770, Bethesda, MD 20892, 301–267– 9270, newmanjh@mail.nih.gov Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Topics in Drug Resistance and Drug Discovery Date: March 7–8, 2013 Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting) Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3214, MSC 7808, Bethesda, MD 20892, 301–435– 2306, boundst@csr.nih.gov Name of Committee: AIDS and Related Research Integrated Review Group; Behavioral and Social Consequences of HIV/ AIDS Study Section Date: March 7–8, 2013 Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications Place: Sheraton Delfina Santa Monica Hotel, 530 West Pico Boulevard, Santa Monica, CA 90405 Contact Person: Mark P Rubert, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301–806– 6596, rubertm@csr.nih.gov Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Risk, Prevention and Health Behavior Date: March 7–8, 2013 Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015 Contact Person: Martha M Faraday, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD 20892, 301–435– 3575, faradaym@csr.nih.gov Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflicts: Asthma, COPD, Cystic Fibrosis and Lung Host Defense Applications Date: March 7–8, 2013 Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications VerDate Mar<15>2010 16:40 Feb 11, 2013 Jkt 229001 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting) Contact Person: Ghenima Dirami, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4122, MSC 7814, Bethesda, MD 20892, 240–498– 7546, diramig@csr.nih.gov (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 6, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–03118 Filed 2–11–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Board of Scientific Advisors, March 4, 2013, 9:00 a.m. to March 5, 2013, 1:00 p.m., National Institutes of Health, Building 31, 31 Center Drive, 6th Floor, Conference Rm. 10, Bethesda, MD, 20892 which was published in the Federal Register on January 24, 2013, 78 FR 5192. This meeting is amended to change it to a one-day meeting to be held on March 4, 2013, from 9:00 a.m. to 5:00 p.m. The meeting is open to the public. confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; R01 Grant Applications. Date: March 1, 2013. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, 6116 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Caterina Bianco, MD, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Suite. 8134, Bethesda, MD 20892–8328, 301–496– 7011, biancoc@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 6, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–03115 Filed 2–11–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: February 6, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2013–03116 Filed 2–11–13; 8:45 am] Notice is hereby given of a change in the meeting of the National Cancer Institute Special Emphasis Panel, March 25, 2013, 8:00 a.m. to March 25, 2013, 5:00 p.m., Hilton Washington DC North—Gaithersburg, 620 Perry Parkway, Gaithersburg, MD, 20877 which was published in the Federal Register on January 14, 2013, 78 FR 5190. This notice is being amended to change the title to ‘‘Novel Imaging Agents to Expand the Clinical Toolkit’’. The meeting is closed to the public. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose PO 00000 Frm 00050 Fmt 4703 Sfmt 9990 National Cancer Institute; Amended Notice of Meeting Dated: February 6, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–03114 Filed 2–11–13; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\12FEN1.SGM 12FEN1

Agencies

[Federal Register Volume 78, Number 29 (Tuesday, February 12, 2013)]
[Notices]
[Page 9932]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03116]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Board of Scientific Advisors, March 4, 2013, 9:00 a.m. 
to March 5, 2013, 1:00 p.m., National Institutes of Health, Building 
31, 31 Center Drive, 6th Floor, Conference Rm. 10, Bethesda, MD, 20892 
which was published in the Federal Register on January 24, 2013, 78 FR 
5192.
    This meeting is amended to change it to a one-day meeting to be 
held on March 4, 2013, from 9:00 a.m. to 5:00 p.m. The meeting is open 
to the public.

    Dated: February 6, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-03116 Filed 2-11-13; 8:45 am]
BILLING CODE 4140-01-P